New test aims to predict dangerous bleeds in cancer patients
NCT ID NCT06386107
Summary
This study is looking for a better way to predict which cancer patients might have serious bleeding while taking blood thinners for a clot. Researchers will measure a specific blood test (thrombin generation) in 212 patients with cancer and a recent blood clot. They will see if the test results are linked to the patient's risk of bleeding over the next six months of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Grenoble
NOT_YET_RECRUITINGGrenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Chu Clermont-Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63003, France
Contact
Contact
Contact
Contact
Contact
Contact
-
Chu St-Etienne
RECRUITINGSaint-Etienne, 42055, France
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
-
HCL
NOT_YET_RECRUITINGLyon, France
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.